Mamounas, E. P., Chen, M., Freeman, T., Stransky, N., Rahman, M. A., Miglarese, M. R., Bandos, H., Cheng, Y., Boucher, T., Varma, M., Ribeiro, J., Anderson, S. J., Bales, C. L., Oberley, M. J., Geyer, C. E., Rastogi, P., Spetzler, D., Sledge, G. W., Wolmark, N. (2025). PRESCIENTai, an AI-based digital histopathological image signature for risk of late distant recurrence and extended endocrine therapy (EET) benefit in hormone receptor–positive breast cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.1556